Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 65CNS 32Genitourinary 20Lymphoid 19Gastrointestinal 19Myeloid 12Dermatologic 6Gynecologic 4Other hematologic neoplasm 3Endocrine 3Plasma cell 2Other solid neoplasm 2Thoracic 1Head & Neck 1Breast 1

Conditions

Mesothelioma 58Advanced Solid Tumors 52Mesothelioma, Malignant 51Solid Tumors 43Solid Tumor 35Advanced Solid Tumor 23Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 12Ovarian Neoplasms 10Melanoma 10Esophageal Neoplasms 10Stomach Neoplasms 9Small Cell Lung Carcinoma 9Retinoblastoma 9Carcinoma, Renal Cell 9Unspecified Adult Solid Tumor, Protocol Specific 8Solitary Fibrous Tumor, Pleural 8Sarcoma 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Breast Neoplasms 7Uterine Cervical Neoplasms 6Malignant Solid Tumor 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Solid Tumor, Adult 5Osteosarcoma 5Metastatic Solid Tumors 5Liver Neoplasms 5Colorectal Neoplasms 5

Interventions

cixutumumab 1Immunologic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Rhabdomyosarcoma × Other solid neoplasm × Clear all
NCT00445965 2024-04-04

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
78 enrolled 11 charts
CNSDermatologicGynecologicOther solid neoplasmSarcomaThoracic

Familial ependymoma, Uveal Melanoma, Astrocytoma, Brain Neoplasms, Chondrosarcoma, Ependymoma, Glioblastoma, Glioma, Lung Neoplasms, Medulloblastoma, Melanoma, Neoplasm Metastasis, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Glioma, Subependymal, Gliosarcoma, Rhabdoid Tumor, Optic Nerve Glioma, Small Cell Lung Carcinoma, Desmoplastic Small Round Cell Tumor

NCT00831844 2015-03-30

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
116 enrolled 8 charts
CNSEndocrineGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Hepatoblastoma, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡